Global CHA Network

CHA Medical Group

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No	Patent Grants
11	[KR] Composition for preventing or treating ultraviolet-induced skin damage (Registration number 10-1026069)
10	[KR] Process for culturing epidermal skin stem cells and composition for wrinkle-caring or promoting hair growth comprising the epidermal skin stem cells obtained by the process
9	[KR] Composition for wound-healing or promoting wound-healing (Registration number 10-1023400)
8	[KR] A process for the differentiation of vascular endothelial progenitor cells from embryoid bodies derived from embryonic stem cells using hypoxic media condition
7	[KR] Cell delivery system for the cell therapy comprising cells derived from embryonic stem cells (Registration number 10-0984376)
6	[KR] Process for the high-purity isolation of mesenchymal stem cells derived from placental chorionic plate membrane (Registration number 10-0900309)
5	[KR] A composition for treating urinary incontinencecomprising umbilical cord blood stem cells (Registration number 10-0757265)
4	[KR] A process for isolating vascular endothelial cells fromembryoid bodies differenciated from embryonic stemcells (Registration number 10-0744440)
3	[KR] A method for culturing human embryonic stem cells (Registration number 10-0744445)
2	[KR] Preparation of cell extract and its application forcell―free protein systhesis (Registration number 10-0733712)